Keros Therapeutics Inc
KROS
Market Cap$546.28M
Close$
$13.86
0.3% downside
Current Fair Value
0.3% downsideOvervalued by 0.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $546.28 Million |
|---|---|
| Enterprise Value | $-142,499,870.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-5 |
| Beta | 1.3 |
| Outstanding Shares | 40,559,355 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 129.52 |
|---|---|
| PEG | -29.15 |
| Price to Sales | 2.78 |
| Price to Book Ratio | 0.82 |
| Enterprise Value to Revenue | -0.66 |
| Enterprise Value to EBIT | 35.45 |
| Enterprise Value to Net Income | -34 |
| Total Debt to Enterprise | -0.22 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
ESG Score
No data